A multicentre observational study assessing switching effect from every day (FTY-ED) Fingolimod to every-other-day (FTY-EOD) in Multiple Sclerosis patients.
Phase of Trial: Phase IV
Latest Information Update: 23 Sep 2016
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 23 Sep 2016 New trial record